Summary:
Meridien Research is now conducting a research study to evaluate an investigational drug in people with Type 2 Diabetes.
Qualified Participants Must:
Have been diagnosed with Type 2 Diabetes
Be between 20 and 75 years of age
Treat your Diabetes with diet and/or exercise alone, stable metformin or other antidiabetic drug
Qualified Participants May Receive:
Study-related care, investigational drug at no cost, and financial compensation may be provided for time and travel.